Shares of Generex Biotechnology Corporation (OTC: GNBT), a development stage company engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases, are soaring in trading today. At last check, GNBT shares were trading 24% higher at $0.0372 on above average volume of 15.56 million. The stock hit an intra-day high of $0.04 earlier today.
GNBT shares are gaining momentum after the company today highlighted the benefits of its AE37 cancer vaccine and technology in the context of a positive cancer immunotherapy forecast recently issued by analysts at Citigroup.
Shares of Crown Marketing (OTC: CWNM), a development-stage company engaged in the wholesale distribution of non-addictive generic pharmaceutical products to distributors, are climbing in trading today. At last check, CWNM shares were trading 8.70% higher at $0.0500 on above average volume of 2.41 million. The stock hit an intra-day high of $0.06 earlier today. CWNM shares have gained nearly 20.50% in the last three trading sessions.
CWNM shares are rallying after the company announced that consumers have given a positive response to its signature specialty items; Raspberry Ketones and the Green Been Coffee Extract.
Shares of Ohr Pharmaceutical Inc. (OTC: OHRP), a biotechnology company, are up sharply in trading today. At last check, OHRP shares were trading 9.74% higher at $2.14 on above average volume of 109,698. The stock hit a 52-week high of $2.17 earlier today. OHRP shares have gained nearly 25.90% in the last three trading sessions.
OHRP shares are climbing after the company presented at the Marcum MicroCap Conference on Thursday.